IL98319A - Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them - Google Patents

Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them

Info

Publication number
IL98319A
IL98319A IL98319A IL9831991A IL98319A IL 98319 A IL98319 A IL 98319A IL 98319 A IL98319 A IL 98319A IL 9831991 A IL9831991 A IL 9831991A IL 98319 A IL98319 A IL 98319A
Authority
IL
Israel
Prior art keywords
radicals
carbon atoms
alkyl
optionally substituted
radical
Prior art date
Application number
IL98319A
Other languages
English (en)
Other versions
IL98319A0 (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9008538A external-priority patent/FR2664271B1/fr
Priority claimed from FR9104882A external-priority patent/FR2675503B1/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IL98319A0 publication Critical patent/IL98319A0/xx
Publication of IL98319A publication Critical patent/IL98319A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
IL98319A 1990-07-05 1991-05-31 Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them IL98319A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9008538A FR2664271B1 (fr) 1990-07-05 1990-07-05 Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR9104882A FR2675503B1 (fr) 1991-04-19 1991-04-19 Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.

Publications (2)

Publication Number Publication Date
IL98319A0 IL98319A0 (en) 1992-06-21
IL98319A true IL98319A (en) 1997-04-15

Family

ID=26228128

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98319A IL98319A (en) 1990-07-05 1991-05-31 Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (3) US5412101A (xx)
EP (1) EP0465368B1 (xx)
JP (2) JP3192171B2 (xx)
KR (1) KR100216006B1 (xx)
CN (1) CN1045769C (xx)
AT (1) ATE166344T1 (xx)
AU (1) AU653160B2 (xx)
CA (1) CA2046265C (xx)
DE (1) DE69129428T2 (xx)
DK (1) DK0465368T3 (xx)
ES (1) ES2117001T3 (xx)
FI (1) FI111542B (xx)
HU (1) HU217444B (xx)
IE (1) IE912335A1 (xx)
IL (1) IL98319A (xx)
MA (1) MA22203A1 (xx)
MX (1) MX9100092A (xx)
OA (1) OA09506A (xx)
RU (1) RU2086542C1 (xx)
UA (1) UA26130A (xx)
WO (1) WO2004074258A1 (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
ATE199548T1 (de) * 1992-06-02 2001-03-15 Sankyo Co 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung
GB9213934D0 (en) * 1992-06-30 1992-08-12 Smithkline Beecham Corp Chemical compounds
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
IT1255461B (it) * 1992-07-28 1995-11-02 Luso Farmaco Inst Eteri di imidazoli ad attivita' a ii antagonista
US5376666A (en) * 1992-11-30 1994-12-27 The Du Pont Merck Pharmaceutical Company Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl
TW259786B (xx) * 1992-12-17 1995-10-11 Sankyo Co
FR2711367B1 (fr) * 1993-10-19 1995-12-01 Roussel Uclaf Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus.
US5395844A (en) * 1993-06-10 1995-03-07 The Du Pont Merck Pharmaceutical Company Imidazole 5-position substituted angiotensin II antagonists
US5409926A (en) * 1993-07-19 1995-04-25 Merck & Co., Inc. AT-2 antagonist inhibition of vascular restenosis
FR2716882B1 (fr) * 1994-03-04 1996-04-05 Roussel Uclaf Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.
BR9509024A (pt) * 1994-09-26 1997-09-30 Shionogi & Co Derivados de imidazol
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19739113A1 (de) * 1997-09-06 1999-03-11 Gefinex Polymerschaeume Gmbh Vorexpandierte polyolefinische Schaumpartikel
DE19820064A1 (de) * 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
KR20010048940A (ko) * 1999-11-30 2001-06-15 서평원 프로세서의 디바이스 제어 시스템
MXPA04001253A (es) * 2001-08-09 2004-06-03 Ono Pharmaceutical Co Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
EP1752450A1 (en) 2005-08-01 2007-02-14 Merck Sante Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US7828840B2 (en) 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2321281A4 (en) 2008-09-02 2011-09-28 Elder Pharmaceuticals Ltd INFLAMMATORY CONNECTIONS
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
JP6807684B2 (ja) * 2016-09-08 2021-01-06 ナブテスコ株式会社 シールアダプタ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179512A (en) * 1977-03-01 1979-12-18 Merck & Co., Inc. 4-Substituted-2-arylimidazoles
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4882348A (en) * 1987-12-29 1989-11-21 Smithkline Beckman Corporation 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids

Also Published As

Publication number Publication date
CA2046265C (fr) 2005-10-18
AU8016391A (en) 1992-01-09
JP3192171B2 (ja) 2001-07-23
JP3261403B2 (ja) 2002-03-04
KR100216006B1 (ko) 1999-08-16
IE912335A1 (en) 1992-01-15
IL98319A0 (en) 1992-06-21
HU217444B (hu) 2000-01-28
US5684028A (en) 1997-11-04
JPH04230369A (ja) 1992-08-19
MA22203A1 (fr) 1992-04-01
CN1058775A (zh) 1992-02-19
EP0465368A1 (fr) 1992-01-08
FI913250A0 (fi) 1991-07-04
AU653160B2 (en) 1994-09-22
ES2117001T3 (es) 1998-08-01
DK0465368T3 (da) 1999-03-08
RU2086542C1 (ru) 1997-08-10
HUT58297A (en) 1992-02-28
CA2046265A1 (fr) 1992-01-06
JP2001151759A (ja) 2001-06-05
MX9100092A (es) 1992-02-28
FI913250A (fi) 1992-01-06
HU912265D0 (en) 1991-12-30
FI111542B (fi) 2003-08-15
EP0465368B1 (fr) 1998-05-20
OA09506A (fr) 1992-11-15
US5599830A (en) 1997-02-04
CN1045769C (zh) 1999-10-20
US5412101A (en) 1995-05-02
WO2004074258A1 (fr) 2004-09-02
UA26130A (uk) 1999-06-07
DE69129428T2 (de) 1998-11-05
KR920002552A (ko) 1992-02-28
DE69129428D1 (de) 1998-06-25
ATE166344T1 (de) 1998-06-15

Similar Documents

Publication Publication Date Title
IL98319A (en) Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
PT80986A (en) Process for the preparation of (used) benz (thio) amides and ofpharmaceutical compositions containing the same
IL112462A0 (en) Substituted aromatic compounds
HUT59562A (en) Cys-carboxamide derivatives, process for producing them and herbicide compositions containing them
ATE138069T1 (de) Schwefel enthaltende kondensierte pyrimidinderivate, ihre herstellung und verwendung
KR910016701A (ko) 제초성 카르복사미드 유도체, 이의 제조 및 제초제로서의 이용
CA2307552A1 (en) Substituted pyridine compounds as anti-inflammatory agents
MA22252A1 (fr) Derives nouveaux de 4-benzylisoxazole, leur procede de production et composition herbicide les contenant
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
ATE141263T1 (de) Pharmazeutisch wirksame zns-verbindung
TW231258B (xx)
CY1111909T1 (el) Παραγωγα [[2-(αμινο-3,4-διοξο-1-κυκλοβουτεν-1-υλ)amino] αλκυλ]-οξεος για τη θεραπεια του πονου
HK1054373A1 (en) Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
DE3070045D1 (en) Use as fungicides of pyridyliminomethylbenzene derivatives and acid-addition salts thereof; pyridyliminomethylbenzene derivatives and their acid-addition salts; a process for preparing such compounds and intermediates for use in such process; and fungicidal compositions comprising such compounds
KR930006005A (ko) 제초제 활성을 보이는 화합물 및 그의 제조 방법
NO940265D0 (no) Fremgangsmaate ved fremstilling av svovelholdige karboksylsyreamider
ES8608482A1 (es) Un procedimiento para preparar bisarilamidas de n,n'-di(1 aminoalquil-2) alquilendiaminas.
DE68910090T2 (de) Verwendung heterozyklischer Amide zur Verhinderung der Tumormetastasierung.
NO302234B1 (no) Cykloheksanderivat og farmasöytisk preparat omfattende dette
KR920016443A (ko) 2,4-및 2,5-비스테트라졸릴피리딘, 이의 제조방법 및 약제로서의 이의 용도
ES8507526A1 (es) Un procedimiento para preparar una 2-(nitrometilen)-tetrahidro-2h-1,3-tiazina sustituida en n
ATE22437T1 (de) Verfahren zur herstellung von 3-(10,11-dihydro-5h-dibenzo /a,d/-cyclohepten-5-yliden)-n,n-dimethyl1-propanamin-n-oxid-dihydrat.
JPS5662837A (en) Stabilization treatment of polyolefin against photodeterioration

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HCE Change of name and address of proprietor(s)
KB Patent renewed
HCA Change of name of proprietor(s) after amalgamation
MM9K Patent not in force due to non-payment of renewal fees